Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Lysosomal Hydrolases01:22

Lysosomal Hydrolases

4.7K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.7K
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

932
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
932

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Re: Pegvaliase Treatment for Adolescents With Phenylketonuria: A Multi-Site Study.

JIMD reports·2026
Same author

Characterizing SMN1 hybrid and deletion alleles using large-scale SNP array-based SMA carrier screening.

BMC medical genomics·2026
Same author

Analysis of purines and pyrimidines across biospecimens: influence of storage temperature and duration.

Scientific reports·2026
Same author

Systemic dual-gene therapy reverses biochemical intoxication in the central metabolic compartment of Bckdha-/- mice.

Molecular therapy : the journal of the American Society of Gene Therapy·2026
Same author

Expert Recommendations for Rapid Response to Positive Newborn Screen for Infantile Krabbe Disease.

Neurology. Genetics·2026
Same author

<i>COASY</i>-Associated Disorders as a Differential Diagnosis in Cases with Newborn Screening Results Suggestive of CPT-I.

International journal of neonatal screening·2026
Same journal

Response to Himanshu Goel.

Genetics in medicine : official journal of the American College of Medical Genetics·2026
Same journal

Evaluation of Electrical Impedance Myography as a Noninvasive Musculoskeletal Biomarker in Infantile- and Late-Onset Pompe Disease.

Genetics in medicine : official journal of the American College of Medical Genetics·2026
Same journal

Correspondence on "Biallelic variants in FAT3 cause axonal neuropathy with multisystem neurodevelopmental features" by Higuchi et al.

Genetics in medicine : official journal of the American College of Medical Genetics·2026
Same journal

RNU4ATAC-opathy: Clinical, molecular and transcriptomic insights from a large cohort.

Genetics in medicine : official journal of the American College of Medical Genetics·2026
Same journal

Expanding the clinical spectrum of RNU4ATAC-opathies: more frequent and diverse than assumed.

Genetics in medicine : official journal of the American College of Medical Genetics·2026
Same journal

Delineating the clinical and molecular spectrum of the neurodevelopmental disorder associated with SET.

Genetics in medicine : official journal of the American College of Medical Genetics·2026
See all related articles

Related Experiment Video

Updated: Feb 19, 2026

One-step Metabolomics: Carbohydrates, Organic and Amino Acids Quantified in a Single Procedure
09:28

One-step Metabolomics: Carbohydrates, Organic and Amino Acids Quantified in a Single Procedure

Published on: June 25, 2010

13.6K

Precision newborn screening for lysosomal disorders.

Melissa M Minter Baerg1, Stephanie D Stoway1, Jeremy Hart2,3

  • 1Biochemical Genetics Laboratory, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.

Genetics in Medicine : Official Journal of the American College of Medical Genetics
|November 10, 2017
PubMed
Summary
This summary is machine-generated.

New informatics tools significantly improved newborn screening accuracy for lysosomal disorders, reducing false positives and associated caregiver stress. This enhances early detection of critical conditions like Krabbe disease, Pompe disease, and MPS I.

Keywords:
Krabbe diseasePompecollaborative laboratory integrated reportdiseasemucopolysaccharidosis type Inewborn screening

More Related Videos

Rapid Detection of Neurodevelopmental Phenotypes in Human Neural Precursor Cells NPCs
10:47

Rapid Detection of Neurodevelopmental Phenotypes in Human Neural Precursor Cells NPCs

Published on: March 2, 2018

10.6K
Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
19:15

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale

Published on: August 25, 2014

88.1K

Related Experiment Videos

Last Updated: Feb 19, 2026

One-step Metabolomics: Carbohydrates, Organic and Amino Acids Quantified in a Single Procedure
09:28

One-step Metabolomics: Carbohydrates, Organic and Amino Acids Quantified in a Single Procedure

Published on: June 25, 2010

13.6K
Rapid Detection of Neurodevelopmental Phenotypes in Human Neural Precursor Cells NPCs
10:47

Rapid Detection of Neurodevelopmental Phenotypes in Human Neural Precursor Cells NPCs

Published on: March 2, 2018

10.6K
Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
19:15

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale

Published on: August 25, 2014

88.1K

Area of Science:

  • Biochemistry
  • Informatics
  • Genetics

Background:

  • Newborn screening for lysosomal disorders faces challenges with poor specificity and high costs.
  • False-positive results cause significant psychosocial harm to caregivers and necessitate expensive follow-up testing.

Purpose of the Study:

  • To report an informatics solution to minimize false positives and improve specificity in newborn screening for lysosomal disorders.
  • To reduce psychosocial harm and financial burden associated with inaccurate screening results.

Main Methods:

  • Implemented multivariate pattern recognition software (Collaborative Laboratory Integrated Reports) integrated with tandem mass spectrometry.
  • Collected and analyzed 55,161 infant specimens for mucopolysaccharidosis type I (MPS I), Pompe disease, and Krabbe disease.

Main Results:

  • Achieved a false-positive rate of 0.0018% and a positive predictive value of 80%.
  • Accurately identified affected infants with Krabbe disease, Pompe disease, and MPS I, distinguishing from heterozygotes.

Conclusions:

  • Postanalytical interpretive tools are effective in drastically reducing false-positive outcomes in newborn screening.
  • Preliminary evidence suggests no increased risk of false-negative events, warranting long-term surveillance.